Research graph
References from Elevated Lipoprotein(a) in Asian Populations and its Implications for Cardiovascular Disease. Local targets link to admitted publications; unresolved targets remain external evidence.
The burden of cardiovascular disease in Asia from 2025 to 2050: a forecast analysis for East Asia, South Asia, South-East Asia, Central Asia, and high-income Asia Pacific regions
2024 · External reference
Lipoprotein(a) and coronary heart disease
10.1161/01.cir.102.10.1082 · 2000 · External reference
Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?
10.1194/jlr.r060582 · 2016 · External reference
Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress
10.1016/j.cmet.2010.09.010 · 2010 · External reference
Association ofLPAVariants with risk of coronary disease and the implications for lipoprotein(a)-lowering therapies
10.1001/jamacardio.2018.1470 · 2018 · External reference
Survey of contemporary cardiac surgery intensive care unit models in the United States
10.1016/j.athoracsur.2019.06.077 · 2020 · External reference
2019 ESC/EAS guidelines for themanagement of dyslipidaemias: lipid modification to reduce cardiovascular risk
10.15829/1560-4071-2020-3826 · 2020 · External reference
Value of measuring lipoprotein(a) during cascade testing for familial hypercholesterolemia
10.1016/j.jacc.2018.12.037 · 2019 · External reference
The copenhagen city heart study (Østerbroundersøgelsen)
10.5339/gcsp.2015.33 · 2015 · External reference
Lipoprotein (a) is a risk factor for coronary artery disease in Chinese Han ethnic population modified by some traditional risk factors: a cross-sectional study of 3462 cases and 6125 controls
10.1016/j.cca.2015.10.009 · 2015 · External reference
Establishing age and sex dependent upper reference limits for the plasma lipoprotein (a) in a Chinese health check-up population and according to its relative risk of primary myocardial infarction
10.1016/j.cca.2018.06.004 · 2018 · External reference
Association between lipoprotein(a) concentration and the risk of stroke in the Chinese Han population: a retrospective case-control study
10.21037/atm.2020.01.38 · 2020 · External reference
Serum lipoprotein (a) is associated with increased risk of stroke in Chinese adults: a prospective study
10.1016/j.atherosclerosis.2019.07.025 · 2019 · External reference
Lipoprotein (a) and its relationship to risk factors and severity of atherosclerotic peripheral vascular disease
10.1016/s1078-5884(97)80220-1 · 1997 · External reference
Serum lipoprotein(a) profiles in a Singaporean population
10.1080/003130299105034 · 1999 · External reference
Impact of lipoprotein(a) level on cardiometabolic disease in the Chinese population: the CHCN-BTH study
10.1111/eci.13689 · 2021 · External reference
Inverse association between serum lipoprotein(a) and cerebral hemorrhage in the Japanese population
10.1016/j.thromres.2012.11.032 · 2013 · External reference
Association between lipoprotein(a) levels, apo(a) isoforms and family history of premature CAD in young Asian Indians
10.1016/j.clinbiochem.2008.01.016 · 2008 · External reference
Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts
10.1016/s0022-2275(20)31172-x · 2001 · External reference
Relook at lipoprotein (A): independent risk factor of coronary artery disease in North Indian population
10.1016/j.ihj.2014.03.002 · 2014 · External reference
Increased risk of coronary artery calcification progression in subjects with high baseline Lp(a) levels: the Kangbuk Samsung health study
10.1016/j.ijcard.2016.07.219 · 2016 · External reference
Lipoprotein (a), metabolic syndrome and coronary calcium score in a large occupational cohort
10.1016/j.numecd.2013.02.009 · 2013 · External reference
Lipoprotein(a) and cardiovascular disease in ethnic Chinese: the Chin-Shan community cardiovascular cohort study
10.1373/clinchem.2007.090969 · 2008 · External reference
Correlation of serum lipoprotein(a) with the clinical presentation of Thai coronary artery disease patients
2000 · External reference
Serum Lipoprotein(a) levels in patients with atherosclerotic peripheral vascular disease in hospital Kuala Lumpur
10.1016/s1015-9584(08)60048-2 · 2008 · External reference
2016 ESC/EAS guidelines for the management of dyslipidaemias
10.1093/eurheartj/ehw272 · 2016 · External reference
Lipoprotein(a)-related cardiovascular and all-cause mortalities in Korean adults
10.1093/eurjpc/zwac271 · 2022 · External reference
Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the study of health assessment and risk in ethnic groups (SHARE)
10.1016/s0140-6736(00)02502-2 · 2000 · External reference
Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, malays, and Chinese in Singapore
10.1136/jech.51.4.394 · 1997 · External reference
Like father like son? Sons of patients of European or Indian origin with coronary artery disease reflect their parents' risk factor patterns
10.1136/hrt.74.3.318 · 1995 · External reference
Predictors of lipoprotein(a) levels in a European and South Asian population in the Newcastle heart project
10.1046/j.1365-2362.2003.01201.x · 2003 · External reference
Lipoprotein(a) as predictor of coronary artery disease and myocardial infarction in a multi-ethnic Asian population
10.1016/j.atherosclerosis.2021.11.018 · 2022 · External reference
Prevalence of high serum lipoprotein (a) in a selected sample of Sri Lankan adults
10.4038/cmj.v47i4.3427 · 2011 · External reference
Sex hormones and lipoprotein(a) concentration
10.1517/13543784.2011.548804 · 2011 · External reference
Hormonal regulation of serum lipoprotein (a) levels: effects of parenteral administration of estrogen or testosterone in males
1996 · External reference
Lack of association between sex hormones and lp(a) concentrations in American and Finnish men
10.1161/01.atv.14.1.19 · 1994 · External reference
Lipoprotein(a) as a cardiovascular risk factor: current status
10.1093/eurheartj/ehq386 · 2010 · External reference
Extreme lipoprotein(a) levels and risk of myocardial infarction in the general population
10.1161/circulationaha.107.715698 · 2008 · External reference
Lipoprotein(a): the revenant
10.1093/eurheartj/ehx033 · 2017 · External reference
Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality
10.1001/jama.2009.1063 · 2009 · External reference
Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women's Health Across the Nation (SWAN)
10.1016/j.ahj.2004.08.027 · 2005 · External reference
Lipoprotein(a)
2001 · External reference
Global variation in Lipoprotein(a) levels among patients with coronary heart disease: insights from the INTERASPIRE study and implications for emerging Lp(a)-lowering therapies
10.1016/j.jacc.2025.04.010 · 2025 · External reference
Lipoprotein(a): an underrecognized genetic risk factor for malignant coronary artery disease in young Indians
10.1016/j.ihj.2019.04.007 · 2019 · External reference
Prognostic impact of lipoprotein(a) levels during lipid management with statins after ST-elevation acute myocardial infarction
10.1097/mca.0000000000000798 · 2019 · External reference
Associations between serum lipoprotein(a) levels and the severity of coronary and aortic atherosclerosis
10.1016/j.atherosclerosis.2012.02.008 · 2012 · External reference
Lipoprotein(a) and lipid profiles of patients awaiting coronary artery bypass graft; a cross sectional study
10.1186/s12872-016-0393-1 · 2016 · External reference
Usefulness of lipoprotein (a) for predicting progression of non-culprit coronary lesions after acute myocardial infarction
10.1253/circj.cj-11-0365 · 2011 · External reference
Lipoprotein(a) as a predictor for the presence and severity of premature coronary artery disease: a cross-sectional analysis of 2433 patients
10.1097/mca.0000000000000940 · 2020 · External reference
Correlation of triglyceride–glucose index and dyslipidaemia with premature coronary heart diseases and multivessel disease: a cross-sectional study in Tianjin, China
10.1136/bmjopen-2022-065780 · 2022 · External reference
Association of lipoprotein(a) levels with recurrent events in patients with coronary artery disease
10.1136/heartjnl-2020-316586 · 2020 · External reference
Predicting cardiovascular outcomes by baseline Lipoprotein(a) concentrations: a large cohort and long-term follow-up study on real-world patients receiving percutaneous coronary intervention
10.1161/jaha.119.014581 · 2020 · External reference
High Lipoprotein(a) levels as a predictor of major adverse cardiovascular events in hospitalized-acute myocardial infarction patients
10.2147/vhrm.s233503 · 2020 · External reference
Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis
10.1016/s2213-8587(17)30088-8 · 2017 · External reference
Association between LDL, Apolipoprotein-B apolipoprotein A-I and Lipoprotein(a) and severity of coronary artery disease based on coronary angiography
10.4236/jbm.2015.38006 · 2015 · External reference
Lipoprotein(a) as a predictor of mortality in hospitalised patients with ischaemic heart disease
10.3389/fendo.2025.1541712 · 2025 · External reference
Prevalence of elevated Lipoprotein(a) and its association with subclinical atherosclerosis in 2.9 million Chinese adults
10.1016/j.jacc.2025.02.032 · 2025 · External reference
Lipoprotein(a) distribution in hospitalised Asian patients with ischaemic heart disease
10.1177/17539447241306936 · 2024 · External reference
Genetically elevated Lipoprotein(a) and increased risk of myocardial infarction
10.1001/jama.2009.801 · 2009 · External reference
Lipoprotein (a) as a predictor of coronary heart disease: the PRIME study
10.1016/s0021-9150(02)00026-6 · 2002 · External reference
Apolipoproteins A–I, A–II and B, lipoprotein(a) and the risk of ischaemic heart disease: the caerphilly study
10.1046/j.1365-2362.2000.00725.x · 2000 · External reference
Apolipoprotein(a) size and lipoprotein(a) concentration and future risk of angina pectoris with evidence of severe coronary atherosclerosis in men: the physicians’ health study
10.1373/clinchem.2003.030031 · 2004 · External reference
Coronary artery disease severity and cardiovascular biomarkers in patients with peripheral artery disease
10.1055/s-0035-1555133 · 2015 · External reference
Lipoprotein(a) is an independent risk factor for peripheral arterial disease in Chinese type 2 diabetic patients in Taiwan
10.2337/diacare.27.2.517 · 2004 · External reference
Lp(a) in severe peripheral artery disease: pilot implementation using LILAC framework
10.70401/alr.2025.0002 · 2025 · External reference
Abstract 499: lipoprotein(a) and carotid intimal medial thickness
10.1161/atvb.37.suppl_1.499 · 2017 · External reference
Lipoprotein(a) and cardiovascular disease in Chinese population
10.1016/j.jacasi.2022.08.015 · 2022 · External reference
Lipid association of India expert consensus statement on management of dyslipidemia in Indians 2020: part III
2020 · External reference
2025 focused update of the 2019 ESC/EAS guidelines for the management of dyslipidaemias
10.1016/j.atherosclerosis.2025.120479 · 2025 · External reference
Lp(a) testing for the primary prevention of cardiovascular disease in high-income countries: a cost-effectiveness analysis
10.1016/j.atherosclerosis.2025.120447 · 2025 · External reference
Lipoprotein (a), apolipoprotein B and other lipid biomarkers in Asian healthcare workers
10.1186/s12944-026-02912-7 · 2026 · External reference
Asian pacific society of cardiology consensus recommendations on dyslipidaemia
10.15420/ecr.2021.36 · 2021 · External reference
